Washington, D.C. — U.S. Senators Ted Budd (R-N.C.) and Chris Coons (D-Del.) introduced the bicameral, bipartisan Biomanufacturing Excellence Act this week, which would promote U.S. leadership in biotechnology and strengthen domestic biopharmaceutical manufacturing. The bill reinvests in domestic biopharmaceutical manufacturing by reducing dependence on unreliable foreign supply chains, expanding access to cutting-edge medicines, and supporting high-quality American jobs.
